The Board of Directors of Bristol-Myers Squibb Company declared a quarterly dividend of forty-five cents ($0.45) per share on the $.10 par value Common Stock of the corporation.
NEW YORK--(BUSINESS WIRE)-- Headline of release should read: “Bristol‑Myers Squibb Announces Dividend” instead of “Bristol‑Myers Squibb Announces Dividend Increase”
The corrected release reads:
BRISTOL‑MYERS SQUIBB ANNOUNCES DIVIDEND
The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty-five cents ($0.45) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on May 1, 2020, to stockholders of record at the close of business on April 3, 2020.
The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable June 1, 2020 to stockholders of record at the close of business on May 5, 2020.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005968/en/
Media:
media@bms.com
609-252-3345
Investors:
Tim Power, 609-252-7509, timothy.power@bms.com
Nina Goworek, 908-673-9711, ngoworek@celgene.com
Source: Bristol-Myers Squibb Company
View this news release online at:
http://www.businesswire.com/news/home/20200302005968/en
